The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as ...

Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...

Integreon Global, working through its business units – Cryopak, DDL and NexKemia – enables pharmaceutical companies to protect product integrity while eliminating cold-chain packaging waste—by closing ...

Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should embrace it.

WASHINGTON, DC – After sparing pharmaceuticals in his earlier trade battles, President Donald Trump is now toying with the sector. On April 8, Trump announced plans to impose a “major” tariff on ...

DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...